This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Insights

Switching Versus Augmentation in Patients With Inadequate Antidepressant Response

Roueen Rafeyan, MD, DFAPA, FASAM; George I. Papakostas, MD; W. Clay Jackson, MD, DipTh; and Madhukar H. Trivedi, MD

Published: May 25, 2000

Expert discuss why clinicians often switch antidepressants before considering augmentation strategies, as well as the potential consequences of those treatment decisions.


Read the eReport

Quick Links: Depression (MDD)

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...